EU food-contact packaging buyers should request a role-specific PFAS evidence package tied to the exact commercial item and revision. For finished packaging, the file should identify the full construction, connect analytical evidence to that construction, and show who holds the PPWR technical documentation and EU Declaration of Conformity. Component and raw-material suppliers should provide product-specific identity, formulation-status, evidence-scope, and change information that the packaging manufacturer can incorporate into its assessment. A generic “PFAS-free” statement, SDS, or unrelated raw-material report cannot support commercial approval. The immediate next step is a Supplier Document Review that classifies every submitted record as mandatory, conditional, or insufficient.

This page is limited to food-contact packaging placed on the EU market under Article 5(5) of Regulation (EU) 2025/40. Other packaging applications and markets require separate scope checks.

Identify What the Supplier Is Actually Supplying

Before requesting documents, determine whether the supplier provides finished packaging, a converted component, a raw material, or distribution services. These parties do not support the same approval decision.

The following is a buyer qualification framework. It does not imply that every document has the same statutory delivery requirement in every transaction.

Article 16 of the PPWR requires suppliers of packaging or packaging materials to provide the manufacturer with information and documentation needed to demonstrate conformity. The packaging manufacturer remains responsible for preparing the technical documentation and, where conformity has been demonstrated, the EU Declaration of Conformity.

The first supplier-screening question is therefore:

Which party controls the composition evidence, and which party will establish conformity for the finished packaging?

What Must the Product Identity Record Establish?

Every PFAS declaration and test report should connect to a controlled product identity. The record should identify:

• Commercial name and item code;
• Legal manufacturer and relevant production site;
• Packaging or formulation revision;
• Intended food-contact use;
• Trial, pilot, or commercial-production status;
• Effective date and covered lots or supply period;
• Materials and components represented by the evidence;
• Unit weight or mass basis used for analytical reporting.

A trade name alone is insufficient. The same name may cover several coating weights, material sources, formulation versions, production sites, or customer-specific structures.

Evidence Boundaries Differ by Packaging Construction

The European Commission’s June 2026 PPWR guidance confirms that food-contact packaging containing recycled material is not excluded from the PFAS restriction.

Component evidence can help locate a possible fluorine source. Commercial approval still requires a documented connection between the component evidence and the packaging configuration being placed on the market.

What Makes a Supplier PFAS Declaration Usable?

A supplier declaration should identify:

• Exact product or component covered;
• PFAS definition and jurisdiction used;
• Formulation or construction revision;
• Legal manufacturer and applicable manufacturing source;
• Whether the conclusion concerns intentional addition, known presence, analytical detection, or compliance with specified concentration limits;
• Treatment of polymeric PFAS, processing aids, impurities, residuals and proprietary upstream components;
• Evidence basis, such as controlled formulation records, upstream declarations, analytical testing, or combined assessment;
• Issue date, effective period and responsible issuer;
• Unresolved or confidential components whose PFAS status has not been confirmed.

These statements have different meanings:

• No intentionally added PFAS describes formulation intent within a defined supply chain.
• No PFAS detected describes the result of a specified analytical method and reporting capability.
• Below a stated limit requires the limit, method, sample and reporting basis to be identified.
• Complies with EU requirements has limited value unless the applicable regulation, packaging revision and supporting evidence are stated.

Complete recipe disclosure is not always necessary. A controlled declaration can protect confidential composition while identifying the product, PFAS definition, evidence category, revision, effective period and any unresolved boundary.

A portfolio-wide or company-wide declaration should not be used to approve a specific packaging item unless it expressly covers that item, formulation, source and supply period.

Which Analytical Evidence Should Buyers Request?

Article 5(5) establishes three PFAS concentration decisions:

• 25 µg/kg for an individual targeted PFAS, excluding polymeric PFAS from quantification;
• 250 µg/kg for the targeted PFAS sum, with precursor degradation where applicable and polymeric PFAS excluded;
• 50 mg/kg for PFAS including polymeric PFAS.

The supplier’s evidence index should state which decision each report addresses. Buyers should avoid requesting every possible analysis automatically.

Total Fluorine Below 50 mg/kg

The Commission’s current guidance recommends total fluorine as the first analytical step and states that a sample below 50 mg/kg could be considered compliant under that recommended enforcement approach.

The report is usable only when it identifies:

• The exact tested packaging or component;
• Commercial or trial status;
• Sample preparation;
• Whole-package, component or other reporting basis;
• Method and laboratory;
• Result, units and measurement uncertainty;
• Packaging revision and test date.

A low total-fluorine result for one raw material cannot automatically cover fluorine introduced through coatings, inks, adhesives, liners, closures or converting operations.

Total Fluorine Above 50 mg/kg

An elevated total-fluorine result does not identify the fluorine source by itself. Article 5(5) provides for evidence concerning fluorine measured as PFAS or non-PFAS when requested for technical documentation.

Commercial approval should remain open until the supplier or responsible manufacturer can explain:

• Whether the fluorine is organic or inorganic;
• Whether PFAS contribute to the result;
• How polymeric PFAS are addressed;
• Which packaging component or material introduces the fluorine;
• Whether the conclusion applies to the current commercial construction.

Targeted or TOP-Related Evidence

For evidence addressing the 25 and 250 µg/kg decisions, the buyer should confirm:

• Targeted analyte list;
• Treatment of precursors;
• LOD and LOQ;
• Sample preparation and extraction;
• Reporting and calculation basis;
• Treatment of non-detects;
• Result uncertainty;
• Packaging identity and revision.

“Not detected” results from two suppliers cannot be compared unless the methods cover comparable substances and have suitable quantification capabilities. A targeted panel also cannot exclude PFAS outside its scope.

Detailed analysis of TF, targeted PFAS, TOP and polymeric-PFAS evidence belongs to the separate decision covered in how to verify PFAS in food-contact packaging under the EU PPWR. The current supplier-document review should record the report’s scope and limitation rather than recreate the full analytical assessment.

What Can SDS, TDS, COA and Food-Contact Documents Prove?

These files may support the supplier review, but they answer different questions.

• SDS: supports hazard communication, handling and certain composition disclosures. Absence of a PFAS entry does not demonstrate absence or PPWR compliance.
• TDS: describes material structure, typical properties and processing information. It does not establish batch-specific PFAS status.
• COA: confirms whether a particular batch meets the parameters listed in its specification. It supports PFAS release only when an appropriate PFAS-related parameter and method are part of the agreed batch specification.
• Food-contact declaration: supports the stated food-contact framework and use conditions. It does not automatically demonstrate compliance with the PPWR PFAS concentration limits.
• Migration report: evaluates transfer under stated test conditions. Article 5(5) concerns PFAS concentration in the packaging, so migration data cannot replace the required concentration evidence.
• EU Declaration of Conformity: records the packaging manufacturer’s conformity conclusion. Its value depends on whether it identifies the correct packaging and is supported by applicable technical documentation.

For finished packaging, buyers should identify whether the supplier is the PPWR manufacturer and request the applicable EU DoC or confirm who will prepare it. For components and raw materials, the priority is obtaining controlled evidence that the packaging manufacturer can incorporate into the finished-package technical file.

How Should Two Suppliers Be Compared?

Supplier evidence should be compared only after aligning five variables:

Same approval question → same packaging object → same regulatory boundary → comparable evidence basis → same commercial stage

A supplier should not be ranked as having “better PFAS compliance” merely because it reports a lower number or uses a stronger-sounding certificate.

Direct comparison should stop when:

• One report covers a finished package and another covers a coating concentrate;
• One declaration addresses intentionally added PFAS and another addresses analytical detection;
• PFAS definitions differ;
• Reporting mass bases differ;
• One result is commercial and another comes from a laboratory trial;
• Analyte lists or LOQs are materially different;
• Documents refer to different manufacturing sites or revisions.

These differences should be resolved before price, lead time or other commercial terms are used to complete the supplier comparison.

When Can the Supplier Be Approved?

Approval of the PFAS documentation file does not automatically establish migration compliance, overall food-contact suitability, recyclability or application performance.

How Should Pilot Evidence Move Into Commercial Approval?

During supplier screening, a product-specific declaration and representative test report may support shortlisting. They do not confirm that future commercial packaging will use the same construction.

Before commercial approval, verify that:

• Commercial item code matches the qualification record;
• Materials, coatings, inks, adhesives and closures match the tested structure;
• Production site and relevant material sources remain unchanged;
• Commercial coating weight and component weight match the reporting basis;
• Applicable technical documentation and conformity records are current;
• Change-notification terms are agreed.

Routine commercial supply does not automatically require a complete PFAS test package for every batch. The monitoring plan should reflect the material risk, supplier controls, production consistency, analytical evidence and consequences of change.

Which Changes Require Reassessment?

Reassessment should be triggered by changes that can alter the earlier PFAS evidence, including:

• Coating, ink, adhesive, primer, liner, sealant or processing-aid changes;
• Formulation or concentration changes;
• Raw-material or critical upstream-supplier changes;
• Manufacturing or converting-site changes;
• Layer structure, coating weight or component-weight changes;
• Recycled-content level or source changes;
• Analytical method, analyte list, LOQ or precursor-treatment changes;
• Product-code or legal-manufacturer changes that break traceability.

An administrative document update may require only record maintenance. A composition, source, construction or analytical change can require a revised declaration, new evidence or formal requalification.

Broader version-management principles are covered in PFAS product tracking, specifications and change control.

Request Only the Evidence Needed to Close the Approval Gap

The minimum supplier-document request should include:

• Exact packaging item, component or raw-material grade;
• Supplier role and legal manufacturer;
• Commercial revision and production source;
• Intended EU food-contact application;
• Current qualification stage;
• Documents already available;
• Specific unresolved evidence question.

Conditional technical requests may add:

• Tested sample and mass basis;
• Method scope, analyte list, LOQ and uncertainty;
• Explanation of total fluorine above 50 mg/kg;
• Commercial-package equivalence;
• Applicable EU DoC or technical-documentation status;
• Change-notification requirements.

Commercial quantity, destination, required packaging and lead time become relevant when the document review advances into an actual sourcing inquiry.

For a specific coating, additive or packaging raw-material inquiry, the ChemicalCell RFQ form can be used to ask whether the applicable specification, supplier documentation and sample status can be confirmed for the required grade. Include the exact material identity, packaging application, evidence requirement and qualification stage so that the request addresses a defined approval gap.